Such investigations will be crucial for safely integrating GLP-1 RAs into comprehensive treatment protocols aimed at optimizing orthopedic care in patients with obesity and/or diabetes. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.